A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration
Clinical trial NCT03814291 · COMPLETED
Trial details
- NCT number
- NCT03814291
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2020-03-05
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.